1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow IMMU-114: new trials by email Literature Review of IMMU-114 trials Research Report on IMMU-114
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I Dose Escalation Study of IMMU-114 in Relapsed or Refractory NHL and CLL IMMU-114 - Non-hodgkin's Lymphoma, Follicular Lymphoma | Phase 1 | Terminated | Gilead Sciences | 30 | 2013-03-01 | 2021-08-19 |
Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Follicular (1) · Lymphoma, Mantle-Cell (1) · Lymphoma, Non-Hodgkin (1)
Gilead Sciences (1)
United States (1)